eletriptan 40 MG Oral Tablet
1 INDICATIONS AND USAGE Eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults. L i m itati o n s of Use: Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with eletriptan hydrobromide tablets, reconsider the diagnosis of migraine before eletriptan hydrobromide tablets are administered to treat any subsequent attacks. Eletriptan hydrobromide tablets are not intended for the prevention of migraine attacks. Safety and effectiveness of eletriptan hydrobromide tablets have not been established for cluster headache. Eletriptan hydrobromide tablets are a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults (1) Limitations of Use: Use only after a clear diagnosis of migraine has been established (1) Not indicated for the prophylactic therapy of migraine (1) Not indicated for the treatment of cluster headache (1)
Amneal Pharmaceuticals LLC
ROUND ORANGE AN 43
Related Pills
eletriptan 20 MG Oral Tablet
Amneal Pharmaceuticals LLC
24 HR levomilnacipran 80 MG Extended Release Oral Capsule
Amneal Pharmaceuticals LLC
Diclofenac Sodium 50 MG Misoprostol 0.2 MG Delayed Release Oral Tablet
Amneal Pharmaceuticals LLC
Diclofenac Sodium 75 MG Misoprostol 0.2 MG Delayed Release Oral Tablet
Amneal Pharmaceuticals LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Eletriptan hydrobromide tablets, 20 mg are light yellow to yellow colored, round shaped, biconvex, film-coated tablets, debossed with “AN” on one side and “42” on other side. Each tablet contains 20 mg of eletriptan (base) as the hydrobromide salt. They are available as follows: Bottles of 30: NDC 65162-042-03 Carton of 6 tablets: NDC 65162-042-80 (Packages of 6 unit doses, 1 card of 6 tablets each) Eletriptan hydrobromide tablets, 40 mg are light orange to dark yellow colored, round shaped, biconvex, film coated tablets, debossed with “AN” on one side and “43” on other side. Each tablet contains 40 mg of eletriptan (base) as the hydrobromide salt. They are available as follows: Bottles of 30: NDC 65162-043-03 Carton of 6 tablets: NDC 65162-043-80 (Packages of 6 unit doses, 1 card of 6 tablets each) Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
More pills like ROUND AN 43